drug relabeling
FDA’s Move to Update GSK’s Leucovorin for Autism Raises Questions on Dose, Supply, and Data
FDA; GSK; leucovorin; Wellcovorin; autism; cerebral folate deficiency; drug relabeling; dose; supply; clinical data
Actionable Insights Powered by AI
FDA; GSK; leucovorin; Wellcovorin; autism; cerebral folate deficiency; drug relabeling; dose; supply; clinical data